MORROW GEORGE J

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$267,996.15
Insider Sells Quantity
12
Insider Sells Sum
$71.13M

Insider Activity of MORROW GEORGE J

According to the SEC Form 4 filings, MORROW GEORGE J, being in a position of

  1. director at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 40000 shares for $5.58M,
    over all time since 2024-03-14, has bought 0 shares, and sold 40000 shares for $5.58M.

The largest purchase of all time was on 2007-12-07 and amounted to 2025 shares of Amgen Inc. for $141,719.

The largest sale of all time was on 2005-07-25 and amounted to 303335 shares of Amgen Inc. for $24.62M.

Biography of MORROW GEORGE J

No biography is available at this moment.

2024-03-14SaleNeurocrine Biosciences, Inc.
NBIX
director
40,000
0.0396%
$139.42$5.58M-2.71%
2021-08-02SaleAlign Technology, Inc.
ALGN
director
5,000
0.0064%
$707.34$3.54M-27.55%
2021-02-08SaleAlign Technology, Inc.
ALGN
director
15,000
0.0197%
$624.60$9.37M+1.51%
2020-11-04SaleAlign Technology, Inc.
ALGN
director
5,000
0.0063%
$480.03$2.4M+23.18%
2020-10-26SaleAlign Technology, Inc.
ALGN
director
17,273
0.0225%
$465.62$8.04M+30.56%
2016-05-23SaleAlign Technology, Inc.
ALGN
director
50,000
0.0628%
$77.72$3.89M+21.85%
2013-10-22SaleAlign Technology, Inc.
ALGN
director
75,000
0.0934%
$57.27$4.3M-4.38%
2009-06-09SaleAmgen Inc.
AMGN
Exe VP, Global Commercial Ops
21,000
0.0021%
$51.07$1.07M+13.16%
2008-10-24SaleAmgen Inc.
AMGN
Exe VP, Global Commercial Ops
57,394
0.0036%
$38.36$2.2M-0.56%
2008-05-15PurchaseAlign Technology, Inc.
ALGN
director
10,000
0.0143%
$12.63$126,277-28.39%
2007-12-07PurchaseAmgen Inc.
AMGN
Exe VP, Global Commercial Ops
2,025.42
0.0002%
$69.97$141,719-8.71%
2005-07-25SaleAmgen Inc.
AMGN
Exe VP, Global Commercial Ops
303,335
0.0246%
$81.15$24.62M-7.31%
2004-11-23SaleAmgen Inc.
AMGN
Exe VP, Global Commercial Ops
59,998
0.0047%
$59.57$3.57M+5.5%
2000-10-26SaleAlign Technology, Inc.
ALGN
director
5,454
0.4513%
$468.78$2.56M
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.